Skip to main content

Main menu

About us
Entrepreneurs
Advisers
Investors
Portfolio
News
Client login

Client login
UK
US

Investor Evening

Thursday, 5 December 2019 - 17:00

Venue:

Edinburgh

Please contact Par Equity for details

Our numbers¹

359

EIS qualifying investment rounds

Our awards

EIS Impact Award 2022 - Winner

Par Equity was recognised for its highly impactful investment and eventual realisation of Current Health, which was sold in October 2021 for $400m, making it Europe's second largest digital health exit ever.

Our accreditations and partnerships

B Corp

BVCA

Linc Scotland

UKBAA

BBI

Par Equity LLP
3A Dublin Meuse
Edinburgh, EH3 6NW

Contact us

info@parequity.com

+44 (0)131 556 0044

UK
US

This is the Par Equity UK website

Find us

Terms of Use and Disclaimers
Privacy Policy
Remuneration Disclosure Statement
Cyber Essentials Plus Certified
Cookies

© 2024. Par Equity LLP is a limited liability partnership incorporated in Scotland (registered number SO301563). Our registered office is 3a Dublin Meuse, Edinburgh, EH3 6NW.

Par Fund Management Limited is a subsidiary of Par Equity LLP and incorporated in Scotland (registered number SC338649). It is authorised and regulated by the Financial Conduct Authority. The FCA firm reference number is 485668 and further information can be found on the Financial Services Register.

VAT registration number: 927582982.

¹ As at 31st December 2023. Past performance should not be seen as an indication of future performance and any references to past or forecasted performance should not be relied upon as a guarantee of future returns.